• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
O6-Benzylguanine

O6-Benzylguanine

Product ID B1855
Cas No. 19916-73-5
Purity ≥98%
Product Unit SizeCostQuantityStock
50 mg $84.50 In stock
250 mg $352.30 In stock
1 g $1,056.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

O6-Benzylguanine (O6-BG) is a synthetic derivative of guanine often used to examine DNA repair mechanisms. O6-BG acts as an inhibitor of O6-methylguanine DNA methyltransferase (MGMT), an enzyme that repairs damage to guanine residues in DNA. As many alkylating and cross-linking chemotherapeutics act on guanine residues to induce DNA damage in cancer cells, O6-BG prevents the repair of the damaged DNA, allowing apoptosis and other mechanisms of cell death to occur. In animals and humans, O6-BG shows some benefit in improving efficacy of co-administered treatments, potentially increasing survival time. This compound is currently in clinical trials examining its anticancer chemotherapeutic potential.

Product Info

Cas No.

19916-73-5

Purity

≥98%

Formula

C12H11N5O

Formula Wt.

241.25

IUPAC Name

6-phenylmethoxy-7H-purin-2-amine

Appearance

White Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

B1855 MSDS PDF

Info Sheet

B1855 Info Sheet PDF

References

Qian L, Zheng J, Wang K, et al. Cationic core-shell nanoparticles with carmustine contained within O6-benzylguanine shell for glioma therapy. Biomaterials. 2013 Nov;34(35):8968-78. PMID: 23953782.

Quinn JA, Jiang SX, Reardon DA, et al. Phase II trial of temozolomide plus O6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. J Clin Oncol. 2009 Mar 10;27(8):1262-7. PMID: 19204199.

Quinn JA, Jiang SX, Carter J, et al. Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme. Clin Cancer Res. 2009 Feb 1;15(3):1064-8. PMID: 19188181.

Friedman HS, Keir S, Pegg AE, et al. O6-benzylguanine-mediated enhancement of chemotherapy. Mol Cancer Ther. 2002 Sep;1(11):943-8. PMID: 12481416.

Friedman HS, Pluda J, Quinn JA, et al. Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol. 2000 Oct 15;18(20):3522-8. PMID: 11032594.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • D324094

    Diclofenac Related Compound A

    Impurity of diclofenac

    ≥98%
  • T1605

    Tebuconazole

    Triazole; 14-α demethylase inhibitor, voltage-...

    ≥98%
  • T1776

    D-Tetrahydropalmatine

    Alkaloid found in Corydalis; D1 antagonist, org...

    ≥99%
  • C344761

    Citalopram Chloromethyl Quaternary Ammonium Chloride

    Citalopram analog

    ≥95%
  • D5869

    Doripenem Hydrate

    β-lactam carbapenem; penicillin binding protei...

    ≥99%
  • K9200

    KX1-004

    Indole; Src inhibitor.

    ≥98%
  • A4926

    AMG-458

    c-MET inhibitor.

    ≥98%
  • D0005

    Dabrafenib Mesylate

    B-Raf and c-Raf inhibitor.

    ≥98%
  • M9356

    Myomodulin

    Proton pump inhibitor

    ≥95%
  • G3358

    Ginkgolide ABC

    Mixture of Ginkgolides A, B and C, found in Gin...

    ≥98%
  • L9600

    LY-2090314

    GSK-3 inhibitor.

    ≥98%
  • M4454

    MLN-4924

    Nedd8-activating enzyme inhibitor.

    ≥99%
  • C9878

    Cytochalasin A

    Mycotoxin produced by Aspergillus; actin polyme...

    ≥98%
  • B8274

    Buspirone Hydrochloride

    Azapirone; α1-adrenergic and 5-HT1A partial ag...

    ≥98%
  • Z0252

    Zanamivir

    Neuraminidase inhibitor.

    ≥98%
  • T3200

    Ticagrelor

    Nucleoside (adenosine) analog; P2Y12 antagonist...

    ≥98%
  • T6902

    Tranilast

    Mast cell stabilizer; TRPV2 antagonist, PDGFR i...

    ≥98%
  • C6935

    Crizotinib

    ALK, ROS1, c-MET inhibitor.

    ≥98%
  • C0148

    Calcitonin, human

    Endogenous neuropeptide hormone, lowers extrace...

    ≥95%
  • M9643

    Myelin Basic Protein (1-11), human

    Peptide antigen fragment

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only